Parameter category | % NSAE | Crude OR (95%-CI) | P-value |
---|---|---|---|
Sex | |||
Male | 509 (76.0) | 3.9 (2.9–5.4) | < 0.001 |
Female | 122 (44.4) | 1 | |
Age (years) | |||
≤ 18 | 14 (22.2) | 1 | |
19–35 | 301 (74.7) | 10,3 (5.5–19.5) | < 0.001 |
≥ 36 | 316 (65.9) | 6.8 (3.6–12.7) | < 0.001 |
Alcohol consumption 24 h before ivermectin treatment | |||
Yes | 181 (87.9) | 4.6 (2.9–7.6) | < 0.001 |
No | 450 (60.9) | 1 | |
Hemp consumption 24 h before ivermectin treatment | |||
Yes | 89 (80.9) | 2.3 (1.4–3.9) | < 0.001 |
No | 542 (64.9) | 1 | |
Associated diseases | |||
Loiasis | |||
Yes | 590 (68.8) | 2.5 (1.6–3.9) | < 0.001 |
No | 41 (46.6) | 1 | |
Uncomplicated malaria | |||
Yes | 610 (66.7) | 1 | |
No | 21 (70.0) | 1.2 (0.5–2.6) | 0.703 |
Diabetes | |||
Yes | 12 (100.0) | NA | |
No | 619 (66.4) |